Tempus AI director sells 250 shares in 10b5-1 trade
Tempus AI, Inc. director David R. Epstein reported an open-market sale of 250 shares of Class A Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Tempus AI, Inc. director David R. Epstein reported an open-market sale of 250 shares of Class A Common Stock. The shares were sold at a price of $50.69 per share on March 2, 2026. After this transaction, Epstein directly holds 25,801 shares of Tempus AI Class A Common Stock. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2024, which is designed to allow insiders to sell shares according to a preset schedule.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 250 | $50.69 | $13K |
Footnotes (1)
- F1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Tempus AI (TEM) disclose for David R. Epstein?
Was the Tempus AI (TEM) insider sale by David R. Epstein under a Rule 10b5-1 plan?
What type of security did Tempus AI (TEM) director David R. Epstein sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.